Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfredi Rizzo

Showing results (121-130 of 522) with videos related to

Pageof 53
Sort By:
Metabolites|November 26, 2024
The Role of Lipid Metabolism in Dyslipidemias and AtherosclerosisMiodrag Janić, Shizuya Yamashita, Ta-Chen Su, et al.
Journal of Diabetes and Its Complications|March 9, 2025
Integrating social determinants of health into global approaches to early-onset type 2 diabetesJ Eleanor Seo, Manfredi Rizzo, Tiffany M Powell-Wiley
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 7, 2007
Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiencyManfredi Rizzo, Roman Trepp, Kaspar Berneis, et al.
American Journal of Obstetrics and Gynecology|January 2, 2008
How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?Manfredi Rizzo, Kaspar Berneis, Enrico Carmina, et al.
Endocrine Connections|May 2, 2018
Metabolic disorders during pregnancy and postpartum cardiometabolic riskAngelo Maria Patti, Kalliopi Pafili, Nikolaos Papanas, et al.
Diabetes/Metabolism Research and Reviews|June 28, 2020
Hydroxychloroquine, COVID-19 and diabetes. Why it is a different storyAnca Pantea Stoian, Doina Catrinoiu, Manfredi Rizzo, et al.
Diabetes Research and Clinical Practice|May 22, 2023
Has the time come to step up to "triple therapy" for the treatment of diabetic kidney disease?Dimitrios Patoulias, Djordje S Popovic, Nikolaos Fragakis, et al.
Metabolites|May 26, 2023
Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and AtherosclerosisShizuya Yamashita, Manfredi Rizzo, Ta-Chen Su, et al.
Metabolites|February 25, 2022
The Role of the Metabolome and Non-Coding RNA on Pheochromocytomas and Paragangliomas: An UpdateBruno Bouça, Paula Bogalho, Manfredi Rizzo, et al.
Clinical Endocrinology|July 20, 2016
Can the effects of gender, menopause and ageing on lipid levels be differentiated?Dragana Nikolic, Maciej Banach, Dimitri P Mikhailidis, et al.
Pageof 53

Showing results (121-130 of 522) with videos related to

Sort By:
Pageof 53
Metabolites|November 26, 2024
The Role of Lipid Metabolism in Dyslipidemias and AtherosclerosisMiodrag Janić, Shizuya Yamashita, Ta-Chen Su, et al.
Journal of Diabetes and Its Complications|March 9, 2025
Integrating social determinants of health into global approaches to early-onset type 2 diabetesJ Eleanor Seo, Manfredi Rizzo, Tiffany M Powell-Wiley
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 7, 2007
Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiencyManfredi Rizzo, Roman Trepp, Kaspar Berneis, et al.
American Journal of Obstetrics and Gynecology|January 2, 2008
How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?Manfredi Rizzo, Kaspar Berneis, Enrico Carmina, et al.
Endocrine Connections|May 2, 2018
Metabolic disorders during pregnancy and postpartum cardiometabolic riskAngelo Maria Patti, Kalliopi Pafili, Nikolaos Papanas, et al.
Diabetes/Metabolism Research and Reviews|June 28, 2020
Hydroxychloroquine, COVID-19 and diabetes. Why it is a different storyAnca Pantea Stoian, Doina Catrinoiu, Manfredi Rizzo, et al.
Diabetes Research and Clinical Practice|May 22, 2023
Has the time come to step up to "triple therapy" for the treatment of diabetic kidney disease?Dimitrios Patoulias, Djordje S Popovic, Nikolaos Fragakis, et al.
Metabolites|May 26, 2023
Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and AtherosclerosisShizuya Yamashita, Manfredi Rizzo, Ta-Chen Su, et al.
Metabolites|February 25, 2022
The Role of the Metabolome and Non-Coding RNA on Pheochromocytomas and Paragangliomas: An UpdateBruno Bouça, Paula Bogalho, Manfredi Rizzo, et al.
Clinical Endocrinology|July 20, 2016
Can the effects of gender, menopause and ageing on lipid levels be differentiated?Dragana Nikolic, Maciej Banach, Dimitri P Mikhailidis, et al.
Pageof 53